HRT FINANCIAL LP

Position in NVCR — NovoCure Ltd

CIK 1475597 NEW YORK, NY

Position in NVCR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,943,632

+$2,699,987 QoQ

Shares Held

392,319

+56.4% QoQ

Ownership

0.337%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#38

of 211 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $195,786,493 across 48 Medical Devices names. NVCR ranks #8 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	1,507,089	$64,322,558
2	MDT	Medtronic plc	381,816	$29,869,465
3	ESTA	Establishment Labs Holdings Inc.	235,980	$20,249,443
4	TMDX	TransMedics Group, Inc.	165,106	$10,966,340
5	BRKR	Bruker Corp	147,460	$9,672,478
6	SNN	Smith & Nephew PLC	281,007	$8,095,811
7	GEHC	GE HealthCare Technologies Inc.	97,904	$6,266,835
8	NVCR	NovoCure Ltd This page	392,319	$5,943,632

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,943,632	392,319	+56.4%	Shares	Defined	2026-08-14
2025-12-31	$3,243,645	250,862	-31.0%	Shares	Defined	2026-02-12
2025-09-30	$4,696,910	363,538	+609.9%	Shares	Defined	2025-11-14
2025-06-30	$911,538	51,210	-42.3%	Shares	Defined	2025-08-14
2024-03-31	$1,386,849	88,730	-49.8%	Shares	Defined	2024-05-13
2023-12-31	$2,640,385	176,851	+393.3%	Shares	Defined	2024-02-09
2023-09-30	$579,025	35,853	+38.4%	Shares	Defined	2023-11-13
2022-09-30	$1,968,489	25,908	+519.1%	Shares	Defined	2022-11-14
2022-06-30	$290,857	4,185	-85.4%	Shares	Defined	2022-08-12
2021-12-31	$2,152,618	28,671	-41.2%	Shares	Defined	2022-02-14
2021-09-30	$5,660,499	48,726	-0.7%	Shares	Defined	2021-11-15
2020-06-30	$2,910,918	49,088	+646.1%	Shares	Defined	2020-08-14
2020-03-31	$443,029	6,579	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.